Results 61 to 70 of about 7,977 (217)

A case of giant prolactinoma and pituitary hemorrhage with the late recovery of pituitary function: A case report

open access: yesSAGE Open Medical Case Reports, 2023
Hypogonadotropic hypogonadism is a common finding in patients who are diagnosed with a prolactinoma. It can be accompanied by the presence of other pituitary hormone deficits, including secondary adrenal insufficiency and central hypothyroidism.
Lakshmi P Menon, Dinesh Edem
doaj   +1 more source

Polycystic Ovary Syndrome and Subjective and Objective Assessments of Sleep Quality: A Systematic Review and Meta‐Analysis

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Sleep disturbances are increasingly recognized in women with polycystic ovary syndrome (PCOS), but the evidence remains inconsistent. We conducted a meta‐analysis to evaluate objective sleep abnormalities and subjective sleep complaints in women with PCOS.
Arefeh Tabashiri   +3 more
wiley   +1 more source

An uncommon cause of osteoporosis

open access: yesJournal of Family Medicine and Primary Care, 2018
Osteoporosis in the younger age group is an important cause of morbidity. Prolactinoma is an uncommon but reversible cause of osteoporosis. The main mechanisms of osteoporosis in prolactinoma are reduced osteoblast activity and hypogonadism. A high index
Rohit Barnabas   +5 more
doaj   +1 more source

Transcriptional Profiling of Growth Hormone–Secreting Pituitary Adenoma Stem‐Like Cells: Unveiling the Significant Role of CXCR4 in Tumorigenesis and Clinical Applications

open access: yesMedComm, Volume 7, Issue 9, September 2026.
Growth hormone–secreting pituitary adenomas harbor hPASCs (human pituitary adenoma stem‐like cells). Genetic profiling of hPASCs identified CXCR4 as a significant gene orchestrating a regulatory network in the self‐renewal and differentiation of hPASCs, as well as the modulation of tumor cells and the microenvironment.
LinHao Yuan   +11 more
wiley   +1 more source

ACTH suppression and adverse effects of cabergoline in horses with pituitary pars intermedia dysfunction

open access: yesEquine Veterinary Education, Volume 38, Issue 9, Page e622-e630, September 2026.
Summary Background The diagnosis and management of pituitary pars intermedia dysfunction (PPID) in horses includes evaluating abnormal plasma concentrations of adrenocorticotrophic hormone (ACTH). Treatment commonly includes the oral dopamine agonist pergolide mesylate, which suppresses the pathologic overproduction of ACTH.
A. Bracken   +5 more
wiley   +1 more source

Latent Class Analysis of Negative Emotion Subtypes and Their Association With Quality of Life in Patients With Pituitary Neuroendocrine Tumors

open access: yesBrain and Behavior, Volume 16, Issue 8, August 2026.
ABSTRACT Introduction Pituitary neuroendocrine tumors (PitNETs) account for up to 15% of intracranial tumors. Patients commonly present with various emotional and cognitive impairments, including a high prevalence of anxiety and depression. Therefore, this study aimed to identify the latent subtypes of negative emotions in patients with PitNETs and ...
Lei Jin   +7 more
wiley   +1 more source

Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma

open access: yes, 2010
P>ObjectiveObjective Although the strong association between hyperprolactinaemia and platelet aggregation is well recognized, there are no studies on changes in coagulation and fibrinolytic status in patients with prolactinoma.
Nuhoglu, Irfan   +4 more
core   +1 more source

Prolactin in high‐metabolic risk pregnancies: Associations with maternal obesity and metabolic health

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1490-1501, August 2026.
Higher maternal BMI before and during early pregnancy is associated with lower prolactin levels across gestation and a reduced prolactin rise. Prolactin in pregnancy may reflect maternal metabolic health and has potential relevance to lactation outcomes.
Kate Rassie   +11 more
wiley   +1 more source

Parathormone-Related Peptide Is Not Associated with Bone Mineral Density in Eugonadal Prolactinoma

open access: yesEndocrinology Research and Practice, 2023
Objective: One of many theories for the cause of osteoporosis in prolactinoma is the increased level of the parathyroid hormone-related peptide. We aimed to assess the parathyroid hormone-related pep- tide levels and its potential effects on bone mineral
Arzu Okyar Baş   +2 more
doaj  

Spectrum of Pituitary disorders: A retrospective study from Basrah, Iraq [version 2; referees: 2 approved]

open access: yesF1000Research, 2018
Background: Pituitary disorders spectrum includes a wide variety of diseases.This study aimed at a comprehensive description of such disorders for patients from  Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) in Basrah (Southern Iraq)
Abbas Ali Mansour   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy